Please login to the form below

Not currently logged in
Email:
Password:

Covance expands its clinical trials capabilities across Asia Pacific

New laboratory doubles CRO’s genomics footprint in Singapore

Clinical research organisation (CRO) Covance has announced the completion of its Singapore laboratory facility expansion.

The New Jersey, US-headquartered CRO says the development will enhance the company's service offerings in the Asia Pacific region.

The Singapore development marks the latest in a number of recent investments the company has made in the region, which includes growth of its operations in China and Japan.

“For the last 13 years Covance has provided central laboratory testing services in Singapore, where we have seen increasing demand for efficient, high-quality clinical trial data and support,” said Jon Koch, corporate VP and global general manager, Central Laboratory Services, Covance.

“This expansion will help us better serve both our local and multinational customers' R&D needs in key therapeutic areas like oncology and metabolic diseases, while reflecting Covance's continued commitment to the Asia Pacific region.”

At approximately 2,700 square metres, the new laboratory is the largest of its kind in Singapore and will provide clinical testing services for clients from South Korea, Taiwan, Hong Kong, the Philippines, Australia and India.

The facility will provide a full-service offering, covering chemistry, immunology, haematology, flow cytometry, genomics, anatomic pathology and microbiology.

Commenting on the investment in Singapore, Kevin Lai, director, Biomedical Sciences Group, from the Economic Development Board of Singapore, said: “Covance's expansion reaffirms Singapore's proposition as a strategic location for CROs to base their regional operations as they expand to tap on the fast growing opportunities in Asia.

“Its investment is a strong vote of confidence in our efforts in developing Singapore as a leading biomedical sciences hub with strong capabilities to support translational and clinical research.”

19th April 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics